VIRX
Viracta Therapeutics, Inc. Common Stock
VIRX
VIRX
Delisted
VIRX was delisted on the 3rd of February, 2025.
58 hedge funds and large institutions have $52.8M invested in Viracta Therapeutics, Inc. Common Stock in 2022 Q3 according to their latest regulatory filings, with 4 funds opening new positions, 16 increasing their positions, 16 reducing their positions, and 8 closing their positions.
Holders
58
Holders Change
-4
Holders Change %
-6.45%
% of All Funds
1%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
4
Increased
16
Reduced
16
Closed
8
Calls
$627K
Puts
$235K
Net Calls
+$392K
Net Calls Change
-$98K
Top Buyers
Top Sellers
1 |
![]()
1
Adage Capital Partners
Boston,
Massachusetts
|
$1.28M |
2 |
2
Millennium Management
New York
|
$642K |
3 |
3
Goldman Sachs
New York
|
$502K |
4 |
HLA
4
Hamilton Lane Advisors
Conshohocken,
Pennsylvania
|
$153K |
5 |
E
5
Ergoteles
New York
|
$566K |